首页> 美国卫生研究院文献>The Journal of Experimental Medicine >The protease inhibitor N-acetyl-L-leucyl-L-leucyl-leucyl-L- norleucinal decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum
【2h】

The protease inhibitor N-acetyl-L-leucyl-L-leucyl-leucyl-L- norleucinal decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum

机译:蛋白酶抑制剂N-乙酰基-L-亮氨酰-L-亮氨酰-亮氨酰-L-正亮氨酸减少主要组织相容性复合物I类结合肽的聚集并抑制内质网中的肽修整

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

N-acetyl-L-leucyl-L-leucyl-L-norleucinal, (LLnL), which inhibits proteasomes in addition to other proteases, was found to prolong the association of major histocompatibility complex class I molecules with the transporters associated with antigen processing (TAP), and to slow their transport out of the endoplasmic reticulum (ER). LLnL induced a reversible accumulation of ubiquitinated proteins and changed the spectrum of peptides bound by class I molecules. These effects can probably be attributed to proteasome inhibition. Unexpectedly, in the TAP-deficient cell line .174, the rate of intracellular transport of human histocompatibility leukocyte antigen (HLA) A2 was also reduced by LLnL, and the generation of most HLA-A2-associated signal sequence peptides was inhibited. The inhibition of HLA-A2 transport in .174 cells was found to be less sensitive to LLnL than in wild-type cells, and a similar difference was found for a second protease inhibitor, benzyloxycarbonyl-L-leucyl-L-leucyl-L-phenylalanilal. These data suggest that under some conditions such inhibitors can block trimming of peptides by an ER peptidase in addition to inhibiting cytosolic peptide generation.
机译:发现N-乙酰基-L-亮氨酰-L-亮氨酰-L-净核糖核酸(LLnL)除其他蛋白酶外还抑制蛋白酶体,从而延长了主要组织相容性复合物I类分子与与抗原加工相关的转运蛋白的结合( TAP),并减缓其从内质网(ER)的运输。 LLnL诱导了遍在蛋白的可逆积累,并改变了由I类分子结合的肽的光谱。这些作用可能归因于蛋白酶体的抑制。出乎意料的是,在TAP缺陷细胞系.174中,LLnL也降低了人类组织相容性白细胞抗原(HLA)A2的细胞内转运速率,并且抑制了大多数HLA-A2相关信号序列肽的产生。发现在.174细胞中对HLA-A2转运的抑制对LLnL的敏感性不如在野生型细胞中,对第二种蛋白酶抑制剂,苄氧羰基-L-亮氨酰-L-亮氨酰-L-苯丙氨醛这些数据表明,在某些条件下,此类抑制剂除了抑制胞质肽的生成外,还可以通过ER肽酶阻断肽的修饰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号